{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06206564",
            "orgStudyIdInfo": {
                "id": "ART-AIN IIB-2"
            },
            "organization": {
                "fullName": "Frantz Viral Therapeutics, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants",
            "officialTitle": "A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Ointment for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)",
            "acronym": "ART-AIN IIB-2",
            "therapeuticArea": [
                "Infectious Diseases",
                "Other"
            ],
            "study": "artesunate-ointment-for-the-treatment-of-anal-hsil-in-hiv-negative-participants"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-03",
            "studyFirstSubmitQcDate": "2024-01-04",
            "studyFirstPostDateStruct": {
                "date": "2024-01-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Frantz Viral Therapeutics, LLC",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Laser Surgery Care, LLC",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Anal Dysplasia Clinic MidWest",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)",
            "detailedDescription": "Eligible participants in this study are randomized 2:1 to receive either artesunate or placebo ointment for the treatment of anal HSIL. Both groups receive four 5-day cycles of ointment, at weeks 0, 2, 4, and 6. Participants are followed closely with anoscopy or high resolution anoscopy (HRA) at weeks 8, 18, 30, and 42. After the week 18 HRA visit, participants who have at least partial response will be followed with HRA at week 30.\n\nParticipants who are found to be non-responders at week 18 will undergo standard of care ablation.\n\nParticipants who are found to have anal HSIL at weeks 30 or 42 will be followed according to standard of care procedures.\n\nPrimary Objective: To evaluate the complete and partial histopathologic response to four 5-day cycles of artesunate ointment in adult patients with biopsy-proven HPV-associated intra-anal HSIL (18 weeks).\n\nSecondary Objectives:\n\nEfficacy:\n\nTo evaluate the viral clearance after four 5-day cycles of artesunate ointment To evaluate complete and partial intra-anal response To evaluate complete and partial peri-anal response To evaluate persistence of response throughout the study window\n\nSafety:\n\nTo evaluate the safety of artesunate ointment for the treatment of intra-anal HSIL."
        },
        "conditionsModule": {
            "conditions": [
                "Anal High-grade Squamous Intraepithelial Lesion",
                "Anal HSIL",
                "Anal HPV Infection"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Double blind, placebo-controlled randomized trial",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "maskingDescription": "Double-blind, placebo-controlled",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 48,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Artesunate",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Artesunate ointment"
                    ]
                },
                {
                    "label": "Placebo ointment",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Artesunate ointment",
                    "description": "Four 5-day cycles of artesunate ointment given at weeks 0, 2, 4, 6",
                    "armGroupLabels": [
                        "Artesunate"
                    ],
                    "otherNames": [
                        "Artesunic acid",
                        "Dihydroartemisinin (DHA)",
                        "Artemisinin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Four 5-day cycles of placebo ointment given at weeks 0, 2, 4, 6",
                    "armGroupLabels": [
                        "Placebo ointment"
                    ],
                    "otherNames": [
                        "placebo ointment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Complete and partial response by week 18",
                    "description": "Number of participants with complete and partial response after four 5-day cycles of artesunate ointment",
                    "timeFrame": "18 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "HPV clearance",
                    "description": "Number of participants who do not have detectable HPV infection",
                    "timeFrame": "42 weeks"
                },
                {
                    "measure": "Complete and partial response after week 18",
                    "description": "Number of participants with complete and partial response after week 18",
                    "timeFrame": "30 weeks"
                },
                {
                    "measure": "Complete and partial peri-anal response after intra-anal ointment application",
                    "description": "Number of participants who have complete and partial peri-anal response after 4 5-day cycles of intra-anal ointment",
                    "timeFrame": "42 weeks"
                },
                {
                    "measure": "Persistence of response",
                    "description": "Number of participants who have complete response and do not have recurrence of anal HSIL",
                    "timeFrame": "42 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Safety of intra-anal artesunate ointment",
                    "description": "Number of participants who do not have any drug-related serious adverse events",
                    "timeFrame": "42 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult men and women age \u2265 18 years\n* Capable of informed consent\n* Biopsy-confirmed intra-anal high-grade dysplasia (AIN 2, AIN 3, anal HSIL) by HRA.\n* Positive anal human papillomavirus (HPV) test.\n* Women of childbearing potential agree to use birth control for the duration of the study.\n* Laboratory values at Screening of:\n\n  1. Serum alanine transaminase (SGPT/ALT) \\< 5 x upper limit of normal (ULN)\n  2. Serum aspartate transaminase (SGOT/AST) \\< 5 x ULN\n  3. Serum Bilirubin (total) \\< 2.5 x ULN\n  4. Serum Creatinine \u2264 1.5 x ULN\n* Electrocardiogram (ECG) with no clinically significant findings as assessed by the Investigator.\n* Weight \u2265 50kg\n\nExclusion Criteria:\n\n* Pregnant and nursing women\n* Diagnosis of low-grade anal dysplasia (AIN 1, LSIL), without the concomitant diagnosis of anal HSIL, by HRA\n* Concurrent anal, vulvar, cervical, or penile cancer\n* HIV-seropositivity\n* Currently receiving systemic chemotherapy or radiation therapy for another cancer.\n* Patients who are on medical treatment with systemic immunosuppressants or steroids (e.g., active autoimmune disease). Participants using nasal steroid treatments for allergic conditions may participate in the study.\n* Concomitant use of strong UGT (Uridine-diphosphate-glucuronosyltransferase) inhibitors\n* Concomitant use of imiquimod or 5-fluorouracil (5-FU) for the duration of the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mihaela Plesa",
                    "role": "CONTACT",
                    "phone": "440-255-1155",
                    "email": "fvtinfo@frantzgroup.com"
                },
                {
                    "name": "Ahmad Bayat, MD",
                    "role": "CONTACT",
                    "phone": "301-956-2523",
                    "email": "ahmadb@amarexcro.com"
                }
            ],
            "locations": [
                {
                    "facility": "Anal Dysplasia Clinic MidWest",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60614",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gary Bucher, MD",
                            "role": "CONTACT",
                            "phone": "312-623-2625",
                            "email": "garybuchermd@adcmidwest.com"
                        },
                        {
                            "name": "Agatha Ngwueke",
                            "role": "CONTACT",
                            "phone": "3126232625"
                        },
                        {
                            "name": "Gary Bucher, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Emily Miller, APN",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Laser Surgery Care",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10011",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Taylor Ridley",
                            "role": "CONTACT",
                            "phone": "212-242-6500",
                            "email": "tridley@lasersurgerycare.com"
                        },
                        {
                            "name": "Joseph Terlizzi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Jonathan Baker, PA-C, MPAS",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Shantice Branch, PA-C",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "No protected health information (PHI) will be shared with other researchers."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000030361",
                    "term": "Papillomavirus Infections"
                },
                {
                    "id": "D000065310",
                    "term": "Squamous Intraepithelial Lesions of the Cervix"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000002278",
                    "term": "Carcinoma in Situ"
                }
            ],
            "ancestors": [
                {
                    "id": "D000015229",
                    "term": "Sexually Transmitted Diseases, Viral"
                },
                {
                    "id": "D000012749",
                    "term": "Sexually Transmitted Diseases"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000004266",
                    "term": "DNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000014412",
                    "term": "Tumor Virus Infections"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000002578",
                    "term": "Uterine Cervical Dysplasia"
                },
                {
                    "id": "D000011230",
                    "term": "Precancerous Conditions"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000002577",
                    "term": "Uterine Cervical Diseases"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23687",
                    "name": "Papillomavirus Infections",
                    "asFound": "HPV Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30502",
                    "name": "Squamous Intraepithelial Lesions of the Cervix",
                    "asFound": "High-Grade Squamous Intraepithelial Lesions",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "High-Grade Squamous Intraepithelial Lesions",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5535",
                    "name": "Carcinoma in Situ",
                    "asFound": "High-Grade Squamous Intraepithelial Lesions",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15558",
                    "name": "Sexually Transmitted Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17933",
                    "name": "Sexually Transmitted Diseases, Viral",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7442",
                    "name": "DNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17162",
                    "name": "Tumor Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M5826",
                    "name": "Uterine Cervical Dysplasia",
                    "relevance": "LOW"
                },
                {
                    "id": "M14111",
                    "name": "Precancerous Conditions",
                    "relevance": "LOW"
                },
                {
                    "id": "M5825",
                    "name": "Uterine Cervical Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "T1074",
                    "name": "Cervical Intraepithelial Neoplasia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077332",
                    "term": "Artesunate"
                },
                {
                    "id": "C000039060",
                    "term": "Artenimol"
                },
                {
                    "id": "D000037621",
                    "term": "Artemisinins"
                },
                {
                    "id": "C000031327",
                    "term": "Artemisinin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000962",
                    "term": "Antimalarials"
                },
                {
                    "id": "D000000981",
                    "term": "Antiprotozoal Agents"
                },
                {
                    "id": "D000000977",
                    "term": "Antiparasitic Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000012556",
                    "term": "Schistosomicides"
                },
                {
                    "id": "D000000980",
                    "term": "Antiplatyhelmintic Agents"
                },
                {
                    "id": "D000000871",
                    "term": "Anthelmintics"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1769",
                    "name": "Artesunate",
                    "asFound": "Force",
                    "relevance": "HIGH"
                },
                {
                    "id": "M24698",
                    "name": "Artemisinins",
                    "asFound": "Make up",
                    "relevance": "HIGH"
                },
                {
                    "id": "M349055",
                    "name": "Artemisinin",
                    "asFound": "Make up",
                    "relevance": "HIGH"
                },
                {
                    "id": "M189432",
                    "name": "Artenimol",
                    "asFound": "Gonadotropin",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4280",
                    "name": "Antimalarials",
                    "relevance": "LOW"
                },
                {
                    "id": "M4298",
                    "name": "Antiprotozoal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4294",
                    "name": "Antiparasitic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4196",
                    "name": "Anthelmintics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}